Clinical Pharmacology During Pregnancy 2nd Edition

Clinical Pharmacology During Pregnancy 2nd Edition book cover

Clinical Pharmacology During Pregnancy 2nd Edition

Author(s): Donald Mattison (Editor), Lee Ann Halbert

  • Publisher: Academic Press
  • Publication Date: 24 Sept. 2021
  • Edition: 2nd
  • Language: English
  • Print length: 506 pages
  • ISBN-10: 0128189029
  • ISBN-13: 9780128189023

Book Description

Clinical Pharmacology During Pregnancy, Second Edition is written for clinicians, physicians, midwives, nurses, pharmacists and other medical professionals involved in the care of women during pregnancy. The book focuses on the impact of pregnancy on drug disposition and includes coverage of treatments for diseases of specific body systems as well as essential content on dosing and efficacy. This update includes substantially expanded sections on the ethics of pharmacological research in pregnancy and physiologic changes, along with new sections on patient reported outcomes in pregnancy, delivery and postnatal care, and the use of pharmacokinetic and pharmacodynamic approaches to estimate maternal, placental and fetal dosing.

The broad range of this book encompasses analgesics, antiasthmatics, antidepressants, heart and circulatory drugs, vitamins and herbal supplements, and more. Topics in chemotherapy and substance abuse are also covered, as are research issues, including clinical trial design and ethical considerations.

  • Uses an evidence-based approach for therapeutics during pregnancy
  • Presents a summary of specific medications by indication, including up-to-date information on dosing and efficacy in pregnancy for the given indication
  • Includes significant new sections on physiologic changes and the ethics of pharmacological research in pregnancy

Editorial Reviews

Review

Provides an overview on the impact of pregnancy on drug disposition and summarizes the dosing and clinical efficacy of medications during pregnancy

About the Author

Dr. Mattison also serves as Associate Director of the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa. He has held academic, clinical and research appointments, including; Senior Advisor to the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Medical Director of the March of Dimes; Dean of the Graduate School of Public Health at the University of Pittsburgh, Professor of Obstetrics and Gynecology and Interdisciplinary Toxicology at the University of Arkansas for Medical Sciences, and Director of Human Risk Assessment at the FDA National Center for Toxicological Research.

Dr. Mattison earned a BA (Chemistry and Mathematics) from Augsburg College in Minneapolis, MN, an MS (Chemistry) from the Massachusetts Institute of Technology, Cambridge, MA and a MD from the College of Physicians and Surgeons, Columbia University, New York, NY. His clinical training in Obstetrics and Gynecology was at the Sloane Hospital for Women in the Columbia Presbyterian Medical Center in New York. His training in Pharmacology and Toxicology was at the National Institutes of Health, Bethesda, MD.

In 1997, he was elected a Fellow of the American Association for the Advancement of Science, in 1999, a Fellow of the New York Academy of Medicine, in 2000 a member of the Institute of Medicine, in 2005 Distinguished Alumni of Augsburg College and in 2009 a Fellow of the Royal Society of Medicine.

Dr. Lee-Ann Halbert, EdD, JD, RN, MSN, NCSN, CNM, CNE, an Associate Professor of Nursing, is a member of the faculty at the University of South Carolina Beaufort. Dr. Halbert came to the field of Nursing after finding practicing as an attorney was unfulfilling. In her time as a nurse, Dr. Halbert has focused on women’s health, in particular practicing as a Certified Nurse-Midwife, and school nursing.

View on Amazon

电子书代发PDF格式价格30我要求助
未经允许不得转载:Wow! eBook » Clinical Pharmacology During Pregnancy 2nd Edition